Vigorexia
DOI:
https://doi.org/10.62486/agsalud202319Keywords:
Vigorexia, Adonis Complex, Muscle Dysmorphia, Body Image, Anabolic SteroidsAbstract
The article discusses the concept of Vigorexia, also known as the Adonis Complex or Muscle Dysmorphia, which is a mental illness characterized by an obsession with body image, particularly muscularity. It was first named by psychiatrist Harrison G. Pope in the 1990s when studying weightlifters in a Boston gym. Vigorexia leads individuals to perceive themselves as small and weak despite having a muscular appearance. Some experts view Vigorexia as a behavioral addiction, marked by an obsession with exercise and the consumption of substances like anabolic steroids to increase muscle mass. It is often associated with distorted body image and dissatisfaction with one's appearance. The article highlights that Vigorexia has not always been recognized as a distinct disorder and was not initially included in diagnostic manuals. Anabolic steroids, testosterone, and growth hormones are commonly abused substances among individuals with Vigorexia, contributing to physical and mental health problems. Long-term use of these substances can lead to severe health issues, including psychosis. The article also touches on the impact of the COVID-19 pandemic on recreational bodybuilding practitioners, as lockdowns and social distancing measures disrupted their routines, potentially exacerbating anxiety and sadness. Additionally, it distinguishes between general physical activity and bodybuilding, with the latter emphasizing muscle development, strength, and aesthetics. The practice of bodybuilding often involves weightlifting and specialized machinery in gyms. In summary, Vigorexia is a mental disorder characterized by an obsession with muscularity, distorted body image, and the abuse of substances like anabolic steroids. It has physical and mental health consequences and has become more prevalent in recent years, affecting both athletes and non-athletes
References
1. Lorenzo Fernández P, Lorenzo-Velázquez B. Farmacología básica y clínica. 2018.
2. Olivardia R, Pope Jr HG, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry 2000;157:1291-6.
3. Baile JI, González Díaz A, Ramírez Ortiz C, Suárez Andujo P. Imagen corporal, hábitos alimentarios y hábitos de ejercicio físico en hombres usuarios de gimnasio y hombres universitarios no usuarios. Rev Psicol Deporte 2011;20:0353-66.
4. Mitchell L, Murray SB, Cobley S, Hackett D, Gifford J, Capling L, et al. Muscle dysmorphia symptomatology and associated psychological features in bodybuilders and non-bodybuilder resistance trainers: A systematic review and meta-analysis. Sports Med 2017;47:233-59.
5. Guimon J. Los lugares del cuerpo. Paidós; 1999.
6. Peyró CF, Oñate CG. La influencia de modelos somáticos publicitarios en la vigorexia masculina: Un estudio experimental en adolescentes. ZER Rev Estud Comun 2011;16:265-84. https://doi.org/10.1387/zer.4845.
7. Pinel JPJ, Miño E, Sánchez Hoyos MA. Biopsicología. Pearson Educación; 2001.
8. Pope H, Phillips KA, Olivardia R. The Adonis complex: The secret crisis of male body obsession. Simon & Schuster; 2002.
9. Hernández Sampieri R, Mendoza Torres C. Metodología de la Investigación. Lasrutas cuantitativa, cualitativa y mixta. 1.a ed. España: McGraw Hill; 2020.
10. Pope HG, Katz DL, Hudson JI. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry 1993;34:406-9. https://doi.org/10.1016/0010-440X(93)90066-D.
11. Castro R. Diferencias de personalidad, autoconcepto, ansiedad y trastornos de alimentación en deportistas de musculación: Patrones psicológicos asociados a la vigorexia. PhD Thesis. Universidad de Jaén, 2013.
12. Baekeland F. Exercise Deprivation: Sleep and Psychological Reactions. Arch Gen Psychiatry 1970;22:365-9. https://doi.org/10.1001/archpsyc.1970.01740280077014.
13. Baile JI. Vigorexia: Cómo reconocerla y evitarla. Editorial Síntesis; 2005.
14. Martínez Medina F. Trastornos de conducta alimentaria intervención desde el ámbito educativo. vol. 16. 2009.
15. Rodríguez Molina JM. Vigorexia: Adicción, obsesión o dismorfia; un intento de aproximación. Salud Drog 2007;7:289-308.
16. Sobrino Cabra O, Cos Milas A, Gómez Macías V, García Blanco C, Sala Cassola R, Ballesteros García M. Adicciones comportamentales. Conductas socioculturales 2006.
17. Castro CFG, Ferreira R. Vigorexia: Estudio sobre la adicción al ejercicio. Un enfoque de la problemática actual. Universidad de Antioquia, 2007.
18. Muñoz Sánchez R, Martínez Moreno A. Ortorexia y vigorexia: ¿nuevos trastornos de la conducta alimentaria? Trastor Conducta Aliment 2007;5:457-82.
19. Portela Guarín H. Cómo problematizar la Educación Física desde la transición del concepto del cuerpo al de corporeidad. EFDeportes 2002;8:1-8.
20. Cabrera Y, Fanjul C. Influencia de los modelos publicitarios en la adolescencia: Anorexia y vigorexia. Rev Sociol Educ-RASE 2012;5:122-37. https://doi.org/10.7203/RASE.5.2.8313.
21. Raich RM. Imagen corporal. Piramide; 2000.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association; 2011.
23. Lopez-Cuautle C, Vazquez-Arevalo R. Muscle Dysmorphia Diagnostic evaluation: A systematic review. An Psicol 2016;32:405.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association; 2013.
25. Salaberría K, Más MB, Amor PJ, Echeburúa E. Tratamiento del trastorno dismórfico corporal: Una revisión crítica. Rev Psicopatología Psicol Clínica 2000;5:27-43. https://doi.org/10.5944/rppc.vol.5.num.1.2000.3886.
26. Tortora GJ, Derrickson B. Principios de anatomía y fisiología. Médica Panamericana; 2018.
27. Peters R, Copeland J, Dillon P. Anabolic–androgenic steroids: User characteristics, motivations, and deterrents. Psychol Addict Behav 1999;13:232-42. https://doi.org/10.1037/0893-164X.13.3.232.
28. Wroblewska A-M. Androgenic-anabolic steroids and body dysmorphia in young men. J Psychosom Res 1997;42:225-34. https://doi.org/10.1016/S0022-3999(96)00302-9.
29. Armijo JA, Flórez J, Mediavilla A. Farmacología humana. Elsevier Masson; 2014.
30. Aguila F, Mercado A, Palma C. Esteroides androgénicos anabolizantes: Consecuencias en el hombre. Rev Chil Urol 2013:13-7.
31. Snyder PJ, Fricker P. Use of androgens and other hormones by athletes 2018.
32. Fischer MD, Michalakis S, Wilhelm B, Zobor D, Muehlfriedel R, Kohl S, et al. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial. JAMA Ophthalmol 2020;138:643-51. https://doi.org/10.1001/jamaophthalmol.2020.1032.
33. Ursino DJ, Villa J, Katz E, Silva M, Carbone L, Rodríguez Giuranna B, et al. La influencia de la cuarenta en el deporte y ejercicio físico. Observatorio de Psicología Social Aplicada, Facultad de Psicología, Universidad de Buenos Aires, 2020.
34. Lazarus RS. Emotion and adaptation. Oxford University Press; 1999.
35. World Health Organization. Actividad física 2020.
36. Dosíl Díaz J, Caracuel JC. Psicología aplicada al deporte. Editorial Síntesis; 2003.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Luciano Caero, Juliana Libertelli (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
